Variation of matrix metalloproteinase 1 and 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoarthritis

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 1, 2012, Pages 15-20

  Abd Allah, Somia H ^a   Shalaby, Sally M ^a   Pasha, Heba F ^a   El Shal, Amal S ^a   Abou El Saoud, Amany M ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; STROMELYSIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS;

ADULT; AGED; ALLELES; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; OSTEOARTHRITIS; POLYMORPHISM, GENETIC;

EID: 84856258844     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0003     Document Type: Article

References (45)

1. Aigner T, Zein A, Gehrsitz A, et al. (2001) Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44:2777-2789. (Pubitemid 34016197)
2. Andereya S, Streich N, Schmidt-Rohlfing B, et al. (2006) Comparison of modern marker proteins in serum and synovial fluid in patients with advanced osteoarthrosis and rheumatoid arthritis. Rheumatol Int 26:432-438.
3. Arnett Fc, Edworthy SM, Bloch DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324. (Pubitemid 18091653)
4. Barlas O, Sezgin M, Erdal ME, et al. (2009) Association of (1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). Rheumatol Int 29:383-388.
5. Bau B, Gebhard PM, Haag J, et al. (2002) Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46:2648-2657. (Pubitemid 36118928)
6. Bluteau G, Conrozier T, Mathieu P, et al. (2001) Matrix metalloproteinase- 1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 1526:147-158. (Pubitemid 32452250)
7. Constantin A, Lauwers-Cance's V, Navaux F, et al. (2002) Collagenase- 1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study. J Rheumatol 29:15-20. (Pubitemid 34041852)
8. Cowell S, Knauper V, Stewart ML, et al. (1998) Induction of matrix metalloproteinase activation cascades based on membrane type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase -3. Biochem J 331:453-458. (Pubitemid 28182159)
9. Cunnane G, Fitzgerald O, Beeton C, et al. (2001) Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinase 1 in rheumatoid arthritis. Arthritis Rheum 44:2263-2274. (Pubitemid 32977494)
10. Dörr S, Lechtenbohmer N, Rau R, et al. (2004) Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther 6:199-207.
11. Fang S, Jin X, Wang R, et al. (2005) Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 26:481-486. (Pubitemid 40246571)
12. Firestein GS, Paine MM, Boyle DL (1994) Mechanisms of methotrexate action in rheumatoid arthritis: selective decrease in synovial collagenase gene expression. Arthritis Rheum37:193-200. (Pubitemid 24065493)
13. Frisch SM, Ruley HE (1987) Transcription from the stromelysin promoter is induced by interleukin 1 and repressed by dexamethasone. J Biol Chem 262:16300-16304. (Pubitemid 18006056)
14. Gerad-Mizon F, DeGroote P, Lamblin N, et al. (2004) Prognostic impact of matrix metalloproteinase gene polymorphism in patients with heart failure according to the etiology of left ventricular systolic dysfunction. Eur Heart J 25:688-693. (Pubitemid 38579498)
15. Gordon D, Haynes C, Blumenfeld J, Finch SJ (2005) PAWE-3D: Visualizing Power for Association with error in case/control genetic studies of complex traits. Bioinformatics 21:3935-3937. (Pubitemid 41535513)
16. Green MJ, Gough AK, Devlin J, et al. (2003) Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology 42:83-88. (Pubitemid 36131572)
17. Huia, Min WX, Tang J, Cruz TF (1998) Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin 1 induced collagenase and stromelysin expression by bovine chondrocytes. Arthritis Rheum 41:869-876. (Pubitemid 28225788)
18. Hulejová H, Baresová V, Klézl Z, et al. (2007) Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 38:151-156. (Pubitemid 47248299)
19. Ikegawa S (2007) New gene associations in osteoarthritis: what do they provide, and where are we going? Curr Opin Rheumatol 19:429-434. (Pubitemid 47344234)
20. Katrib A, Smith MD, Ahern MJ, et al. (2003) Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission. J Rheumatol 30:10-21. (Pubitemid 36077766)
21. Kellgren J, Lawrence J (1957) Radiological assessment of osteoarthritis. Ann Rheum Dis 16:494-501.
22. Kevorkian L, Young DA, Darrah C, et al. (2004) Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50:131-141. (Pubitemid 38084297)
23. Lee YH, Kim HJ, Rho YH (2003) Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis, Scand. J Rheumatol 32:235-239. (Pubitemid 37266964)
24. Mahmoud RK, El-Ansary AK, El-Eishi HH, et al. (2005) Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis. Ital J Biochem 54:248-257.
25. Massarotti M, Marchesoni A, Biondi ML, Marasini B (2002) Polymorphism in the matrix metalloproteinase-1 promoter gene and severity of rheumatoid arthritis. J Rheumatol 29:2241.
26. Mattey DL, Nixon NB, Dawes PT, et al. (2004) Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 5:147-149. (Pubitemid 38967645)
27. Murphy G, Nagase H (2008) Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol 4:128-135. (Pubitemid 351338627)
28. Nagase H, Okada Y (1997) Proteinases and matrix degradation. In: Kelly WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of Rheumatology. Saunders, Philadelphia, pp 323-341.
29. Nemec P, Pavkova-Goldbergova M, Gatterova J, et al. (2007) Association of the 5A/6A promoter polymorphism of the MMP-3 gene with the radiographic progression of rheumatoid arthritis. Ann N Y Acad Sci 1110:166-176. (Pubitemid 350054764)
30. Peng B, Cao L, Wang W, et al. (2010) Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies. Mutagenesis 25:41-48.
31. Prevoo ML, Van't Hof MA, Kuper HH, et al. (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44-48.
32. Ribbens C, Martin M, Porras Y, et al. (2002) Increased matrix metalloproteinase 3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis 61:161-166. (Pubitemid 34098433)
33. Rodriguez-Lopez J, Perez-Pampin E, Gomez-Reino JJ, et al. (2006) Regulatory polymorphisms in extracellular matrix protease genes and susceptibility to rheumatoid arthritis: a case-control study. Arthritis Res Ther 8:R1.
34. Rutter JL, Mitchel TI, Buttice G, et al. (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321-5325. (Pubitemid 28551108)
35. Scherer S, DeSouza TB, DePaoli J, et al. (2010) Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis. Rheumatol Int 30:369-373.
36. Seifi M, Fallah S, Firoozrai M (2009) Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis. Arch Med Res 40:600-604.
37. Spurr NK, Gough AC, Gosden J, et al. (1988) Restriction fragment length polymorphism analysis and assignment of the metalloproteinases stromelysin and collagenase to the long arm of chromosome 11. Genomics 2:119-127.
38. Tsukahara S, Shinozaki M Ikari K, et al. (2008) Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase- 3 level and outcome measures in Japanese RA patients. Rheumatology 47:41-44. (Pubitemid 350286259)
39. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827-839. (Pubitemid 36542523)
40. White LA, Maute C, Brinckerhoff CE (1997) EST sites in the promoters of the matrix metalloproteinases collagenase (MMP1) and stromelysin (MMP3) are auxiliary elements that regulate basal and phorbol-induced transcription. Tissue Res 36:321-335. (Pubitemid 28214040)
41. Worthington J (2005) Investigating the genetic basis of susceptibility to rheumatoid arthritis. J Autoimmun 25:16-20. (Pubitemid 41728038)
42. Ye S (2000) Polymophism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19:623-629.
43. Ye S, Eriksson P, Hamsten A, et al. (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 27:13055-13060. (Pubitemid 26175880)
44. Ye S, Patodi N, Walker-Bone K, et al. (2007) Variation in the matrix metalloproteinase-3, -7, -12 and -13 genes is associated with functional status in rheumatoid arthritis. Int J Immunogenet 34:81-85. (Pubitemid 46435094)
45. Yoshihara Y, Nakamura H, Obata K, et al. (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455-461. (Pubitemid 30395603)